479 related articles for article (PubMed ID: 19374596)
1. New TNM classification for non-small-cell lung cancer.
Tanoue LT; Detterbeck FC
Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
[TBL] [Abstract][Full Text] [Related]
2. Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee.
Travis WD;
Histopathology; 2009 Jan; 54(1):3-11. PubMed ID: 19187176
[TBL] [Abstract][Full Text] [Related]
3. The revised TNM staging system for lung cancer.
Rami-Porta R; Crowley JJ; Goldstraw P
Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):4-9. PubMed ID: 19262443
[TBL] [Abstract][Full Text] [Related]
4. Non-small cell lung cancer staging: proposed revisions to the TNM system.
Schneider BJ
Cancer Imaging; 2008 Sep; 8(1):181-5. PubMed ID: 18824424
[TBL] [Abstract][Full Text] [Related]
5. Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers.
Fukui T; Mori S; Hatooka S; Shinoda M; Mitsudomi T
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1343-8. PubMed ID: 19026826
[TBL] [Abstract][Full Text] [Related]
6. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
Shepherd FA; Crowley J; Van Houtte P; Postmus PE; Carney D; Chansky K; Shaikh Z; Goldstraw P;
J Thorac Oncol; 2007 Dec; 2(12):1067-77. PubMed ID: 18090577
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
8. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
[TBL] [Abstract][Full Text] [Related]
10. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
Ignatius Ou SH; Zell JA
J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
[TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary metastasis in resected pathologic stage IIIB non-small cell lung cancer: possible contribution of aerogenous metastasis to the favorable outcome.
Aokage K; Ishii G; Nagai K; Kawai O; Naito Y; Hasebe T; Nishimura M; Yoshida J; Ochiai A
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):386-91. PubMed ID: 17662777
[TBL] [Abstract][Full Text] [Related]
12. Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.
Hashizume S; Nagayasu T; Hayashi T; Hidaka S; Tsuchiya T; Tagawa T; Yamasaki N; Furukawa K; Matsumoto K; Miyazaki T
Lung Cancer; 2009 Sep; 65(3):363-70. PubMed ID: 19157635
[TBL] [Abstract][Full Text] [Related]
13. Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry.
Zell JA; Ignatius Ou SH; Ziogas A; Anton-Culver H
J Thorac Oncol; 2007 Dec; 2(12):1078-85. PubMed ID: 18090578
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
Miyoshi K; Moriyama S; Kunitomo T; Nawa S
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
[TBL] [Abstract][Full Text] [Related]
15. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
Ou SH; Zell JA
J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
[TBL] [Abstract][Full Text] [Related]
16. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
17. [The TNM classification. Critical review].
Appere de Vecchi C; Brechot JM; Lebeau B
Rev Mal Respir; 1998 Jun; 15(3 Pt 2):323-32. PubMed ID: 9690302
[TBL] [Abstract][Full Text] [Related]
18. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours.
Groome PA; Bolejack V; Crowley JJ; Kennedy C; Krasnik M; Sobin LH; Goldstraw P; ; ; ;
J Thorac Oncol; 2007 Aug; 2(8):694-705. PubMed ID: 17762335
[TBL] [Abstract][Full Text] [Related]
19. Stage IIIB non-small-cell lung cancer.
Rendina EA; Venuta F; De Giacomo T; Furio Coloni G
Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
[TBL] [Abstract][Full Text] [Related]
20. Considerations about tumor size as a factor of prognosis in NSCLC.
Motta G; Carbone E; Spinelli E; Nahum MA; Testa T; Flocchini GP
Ann Ital Chir; 1999; 70(6):893-7. PubMed ID: 10804668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]